Received Oct 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | — |
patient received only the diluent portion of Shingrix; patient received only the diluent portion of Shingrix; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a 75-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. On 07-JUL-2025, the patient received the 1st dose of Shingrix. On 07-JUL-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: patient received only the diluent portion of Shingrix) and inappropriate dose of vaccine administered (Verbatim: patient received only the diluent portion of Shingrix). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK receipt date: 06-OCT-2025 The pharmacist asked for recommendations on this situation. The batch number was not provided upon follow- up with the reporter.